サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1753860

神経毒の世界市場の機会と2034年までの戦略

Neurotoxin Global Market Opportunities And Strategies To 2034

出版日
ページ情報
英文 320 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
神経毒の世界市場の機会と2034年までの戦略
出版日: 2025年06月20日
発行: The Business Research Company
ページ情報: 英文 320 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の神経毒市場は2019年に52億9,089万米ドルと評価され、2024年まで6.00％以上の複合年間成長率（CAGR）で成長しました。

神経疾患の有病率の上昇

神経疾患の有病率の上昇は、実績期間中の神経毒市場の成長を牽引しました。神経障害は、脳、脊髄、神経に影響を及ぼし、さまざまな身体的、認知的、行動的障害を引き起こす病状です。神経障害は、人口の高齢化、糖尿病のような慢性疾患の増加、汚染のような環境要因、COVID-19のような感染症の長期的影響により、世界的に増加しています。神経毒治療は、異常な神経活動を選択的に標的にしてブロックすることで神経障害を助け、慢性片頭痛、痙縮、特定の運動障害などの症状に治療的緩和を与え、それによって筋肉のコントロールを改善し、症状を軽減します。例えば、2024年7月、米国を拠点とする非営利団体American Brain Foundationによると、2021年、神経疾患による死亡者数は1,110万人にのぼり、世界人口の43.1％にあたる34億人が影響を受けています。さらに2022年4月、ベルギーに本拠を置く非営利団体European Brain Councilによると、600を超える神経疾患と300近くの精神疾患が、世界中で数百万人を苦しめています。したがって、神経疾患の有病率の上昇が神経毒市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

  • 神経毒-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 神経毒市場定義とセグメンテーション
  • 製品タイプ別の市場セグメンテーション
    • ボトックス
    • ディスポート
    • ゼオミン
    • その他の製品
  • 市場セグメンテーション：用途別
    • 治療的
    • 美的
    • その他の用途
  • 市場セグメンテーション：エンドユーザー別
    • 病院
    • 専門クリニック
    • 皮膚科クリニック
    • その他のエンドユーザー

第7章 主要な市場動向

  • 治療および美容用途の拡大に関する規制当局の承認
  • 新製品の発売に注力
  • 革新的な効能とアプリケーションの拡大
  • 市場企業間の戦略的パートナーシップとコラボレーション
  • 革新的な神経毒の開発

第8章 世界の神経毒の成長分析と戦略分析フレームワーク

  • 世界の神経毒PESTEL分析（政治、社会、技術、環境、法的要因）
    • 政治的
    • 経済
    • 社会
    • 技術的
    • 環境
    • 法律上
  • エンドユーザー産業（B2B）の分析
    • 病院
    • 専門クリニック
    • 皮膚科クリニック
    • その他のエンドユーザー
  • 世界の神経毒市場：成長率分析
  • 市場成長実績、2019年～2024年
    • 市場促進要因、2019年～2024年
    • 市場抑制要因、2019年～2024年
  • 市場成長予測、2024年～2029年、2034年
  • 成長予測の貢献要因
    • 量的成長の貢献者
    • 促進要因
    • 抑制要因
  • 世界の神経毒物総アドレス可能市場（TAM）

第9章 世界の神経毒市場：セグメンテーション

  • 世界の神経毒市場：製品タイプ別、実績と予測、2019年～2024年、2029年、2034年
  • 世界の神経毒市場：用途別、実績と予測、2019年～2024年、2029年、2034年
  • 世界の神経毒市場：エンドユーザー別、実績と予測、2019年～2024年、2029年、2034年
  • 世界の神経毒市場、ボトックスの種類別サブセグメンテーション、実績と予測、2019年～2024年、2029年、2034年
  • 世界の神経毒市場、ディスポートのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2029年、2034年
  • 世界の神経毒市場、ゼオミンの種類別サブセグメンテーション、実績と予測、2019年～2024年、2029年、2034年
  • 世界の神経毒市場、その他の製品別、タイプ別サブセグメンテーション、実績と予測、2019年～2024年、2029年、2034年

第10章 神経毒市場：地域・国別分析

  • 世界の神経毒市場：地域別、実績と予測、2019年～2024年、2029年、2034年
  • 世界の神経毒市場：国別、実績と予測、2019年～2024年、2029年、2034年

第11章 アジア太平洋市場

第12章 西欧市場

第13章 東欧市場

第14章 北米市場

第15章 南米市場

第16章 中東市場

第17章 アフリカ市場

第18章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Abbvie Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Ipsen Pharma SA
  • Evolus Inc.
  • Revance Therapeutics Inc.

第19章 その他の大手企業と革新的企業

  • Daewoong Pharmaceutical Co. Ltd.
  • Galderma S.A.
  • Sinclair Pharma plc
  • Croma-Pharma GmbH
  • Supernus Pharmaceuticals Inc.
  • Alphaeon Corporation
  • Hugel Inc.
  • Entod Pharmaceuticals Ltd.
  • Aquavit Pharmaceuticals Inc.
  • Object Pharma Inc.
  • Biotium Inc.
  • Vida Aesthetics Ltd.
  • Medytox Inc.
  • Gufic Biosciences Ltd.
  • AEON Biopharma

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Crown Laboratories Acquired Revance Therapeutics
  • Priveterra Acquisition Corp. Acquired AEON Biopharma Inc.

第23章 最近の動向神経毒市場

第24章 機会と戦略

  • 世界の神経毒市場2029年：新たな機会を提供する国
  • 世界の神経毒市場2029年：新たな機会を提供するセグメント
  • 世界の神経毒市場2029年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 神経毒市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1673

Neurotoxins refer to a class of biological or synthetic substances that adversely affect the structure or function of the nervous system by disrupting neural transmission, damaging nerve cells, or altering neurotransmitter activity.

The neurotoxin market consists of sales, by entities (organizations, sole traders or partnerships), of neurotoxin naturally derived, such as botulinum toxin from clostridium botulinum, or synthetically engineered for therapeutic applications. While certain neurotoxins pose environmental and biological hazards, others are used in controlled doses for medical and cosmetic purposes. In healthcare, purified neurotoxins are primarily used to treat a range of neuromuscular and neurological disorders, including chronic migraine, cervical dystonia, spasticity and hyperhidrosis, as well as for aesthetic treatments to reduce facial wrinkles.

The global neurotoxin market was valued at $5,290.89 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 6.00%.

Rising Prevalence Of Neurological Disorders

The rising prevalence of neurological disorders drove the growth of the neurotoxin market during historic period. Neurological disorders are medical conditions that affect the brain, spinal cord, or nerves, leading to a range of physical, cognitive, or behavioral impairments. Neurological disorders are increasing globally due to aging populations, rising chronic diseases like diabetes, environmental factors such as pollution and the long-term effects of infections like COVID-19. Neurotoxin treatments help neurological disorders by selectively targeting and blocking abnormal nerve activity, providing therapeutic relief for conditions such as chronic migraines, spasticity and certain movement disorders, thereby improving muscle control and reducing symptoms. For instance, in July 2024, according to the American Brain Foundation, a US-based non-profit organization, in 2021, neurological disorders accounted for 11.1 million fatalities and impacted 3.4 billion people, or 43.1% of the world's population. Moreover, in April 2022, according to the European Brain Council, a Belgium-based non-profit organization, over 600 neurological diseases and nearly 300 psychiatric conditions afflict millions globally. Therefore, the rising prevalence of neurological disorders is driving the growth of the neurotoxin market.

Focus On Launch Of New Products

Major companies operating in the neurotoxin market are focusing on launching new products to strengthen their market presence. Product launch is the introduction of a new product or service into the marketplace, accompanied by a series of strategic marketing, distribution, and sales activities aimed at generating awareness, interest, and initial adoption. For example, in September 2024, Allergan Aesthetics, an AbbVie company, launched BOTOX Cosmetic (onabotulinumtoxinA) in China for the treatment of masseter muscle prominence (MMP) in adults. This approval by the China National Medical Product Administration (NMPA) makes BOTOX(R) Cosmetic the first neurotoxin approved in China for this indication. MMP is characterized by an enlarged masseter muscle, leading to a wider, square-shaped lower face, which can be an aesthetic concern for some individuals. The condition may result from genetic factors or activities such as excessive chewing or teeth grinding. Clinical trials demonstrated that treatment with BOTOX(R) Cosmetic resulted in an average reduction of facial width by 5.2mm compared to placebo, with effects typically lasting between six to nine months.

The global neurotoxin markets are highly concentrated, with large players operating in the market. The top 10 competitors in the market made up 68.52% of the total market in 2024.

Neurotoxin Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global neurotoxin market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for neurotoxin? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The neurotoxin market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider neurotoxin market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product type, by application and by end user.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the unmanned underwater vehicles market.
  • Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product type, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for neurotoxin market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product Type: Botox; Dysport; Xeomin; Other products
  • 2) By Application: Therapeutic; Aesthetic; Other Applications
  • 3) By End-User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
  • Companies Mentioned: Abbvie Inc.; Merz Pharma GmbH & Co. KGaA; Ipsen Pharma SA; Evolus Inc.; Revance Therapeutics Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; neurotoxin indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Neurotoxin - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Neurotoxin Market Definition And Segmentations
  • 6.4 Market Segmentation By Product Type
    • 6.4.1 Botox
    • 6.4.2 Dysport
    • 6.4.3 Xeomin
    • 6.4.4 Other Products
  • 6.5 Market Segmentation By Application
    • 6.5.1 Therapeutic
    • 6.5.2 Aesthetic
    • 6.5.3 Other Applications
  • 6.6 Market Segmentation By End User
    • 6.6.1 Hospitals
    • 6.6.2 Specialty Clinics
    • 6.6.3 Dermatology Clinics
    • 6.6.4 Other End Users

7 Major Market Trends

  • 7.1 Regulatory Approvals For Expansion Of Therapeutic And Aesthetic Applications
  • 7.2 Focus On Launch Of New Products
  • 7.3 Innovating Efficacy And Expanding Applications
  • 7.4 Strategic Partnerships And Collaborations Among Market Players
  • 7.5 Innovative Neurotoxin Developments

8 Global Neurotoxin Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Neurotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User Industries (B2B)
    • 8.2.1 Hospitals
    • 8.2.2 Specialty Clinics
    • 8.2.3 Dermatology Clinics
    • 8.2.4 Other End Users
  • 8.3 Global Neurotoxin Market Growth Rate Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Neurotoxin Total Addressable Market (TAM)

9 Global Neurotoxin Market Segmentation

  • 9.1 Global Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Neurotoxin Market, Sub-Segmentation Of Botox, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Neurotoxin Market, Sub-Segmentation Of Dysport, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Neurotoxin Market, Sub-Segmentation Of Xeomin, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Neurotoxin Market, Sub-Segmentation By Other Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Neurotoxin Market, Regional and Country Analysis

  • 10.1 Global Neurotoxin Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Neurotoxin Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Neurotoxin Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Investments
    • 11.9.11 Major Companies
  • 11.10 China Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Investments
    • 11.19.11 Major Companies
  • 11.20 Japan Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 South Korea Market
  • 11.24 Summary
  • 11.25 Market Overview
    • 11.25.1 Country Information
    • 11.25.2 Market Information
    • 11.25.3 Background Information
    • 11.25.4 Government Initiatives
    • 11.25.5 Regulations
    • 11.25.6 Regulatory Bodies
    • 11.25.7 Major Associations
    • 11.25.8 Taxes Levied
    • 11.25.9 Corporate Tax Structure
    • 11.25.10 Investments
    • 11.25.11 Major Companies
  • 11.26 South Korea Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 South Korea Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.28 South Korea Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Australia Market
  • 11.30 Australia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 Australia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.32 Australia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.33 Indonesia Market
  • 11.34 Indonesia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 Indonesia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 Indonesia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Neurotoxin Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major Companies
  • 13.3 Eastern Europe Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Russia Market
  • 13.7 Russia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.8 Russia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Neurotoxin Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulation
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 Brazil Market
  • 15.7 Brazil Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.8 Brazil Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Africa Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Abbvie Inc.
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Merz Pharma GmbH & Co. KGaA
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Financial Overview
  • 18.4 Ipsen Pharma SA
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 Evolus Inc.
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Revance Therapeutics Inc.
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Daewoong Pharmaceutical Co. Ltd.
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Galderma S.A.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Sinclair Pharma plc
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Croma-Pharma GmbH
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 Supernus Pharmaceuticals Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Alphaeon Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Hugel Inc.
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 Entod Pharmaceuticals Ltd.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Aquavit Pharmaceuticals Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Object Pharma Inc.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Biotium Inc.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 Vida Aesthetics Ltd.
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Medytox Inc.
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Gufic Biosciences Ltd.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 AEON Biopharma
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Crown Laboratories Acquired Revance Therapeutics
  • 22.2 Priveterra Acquisition Corp. Acquired AEON Biopharma Inc.

23 Recent Developments In The Neurotoxin Market

  • 23.1 Daewoong Pharmaceutical Introduces NABOTA To Saudi Arabia's Expanding Aesthetic Market
  • 23.2 Oxapharma Launches Clodew As A Breakthrough Toxin For Targeted Therapeutic Treatments
  • 23.3 Godrej Consumer Products Launches Formaldehyde-Free Botosmooth Hair Botox Treatment in Maharashtra

24 Opportunities And Strategies

  • 24.1 Global Neurotoxin Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global Neurotoxin Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global Neurotoxin Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Neurotoxin Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer